Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Represented Tottenham in acquisition of Clene Nanomedicine

Represented Tottenham Acquisition I Limited, a Nasdaq-listed company, in its acquisition of Clene Nanomedicine, Inc., a U.S. clinical-stage biopharmaceutical company.